Pegloticase (Recombinant Uricase) Therapy Monitoring
What is Pegloticase (Recombinant Uricase) Therapy Monitoring?
Pegloticase is a specialized medication used to treat severe gout that has not responded to other treatments. This therapy uses an enzyme that breaks down uric acid in your blood, helping your body get rid of excess uric acid that causes painful gout attacks. The medication is given as an infusion every two weeks.
If you are on pegloticase therapy, regular blood testing is essential to make sure the treatment is working. Your doctor needs to track your uric acid levels to see if the medication is lowering them effectively. Blood tests also help detect a serious problem called neutralizing antibodies, which are proteins your immune system makes that can stop pegloticase from working.
When neutralizing antibodies develop, your uric acid levels start rising again even though you are still getting infusions. Catching this early helps your doctor adjust your treatment plan before you experience severe gout flares or infusion reactions.
Symptoms
- Uric acid levels dropping below 6 mg/dL indicate the therapy is working
- Uric acid levels rising above 6 mg/dL may signal neutralizing antibodies
- Increased gout flares or joint pain despite treatment
- Infusion reactions such as redness, itching, or difficulty breathing
- Return of joint swelling or tophi, which are hard deposits under the skin
- Fever or chills after infusions
Some people develop antibodies without obvious symptoms at first. This is why regular blood testing is critical even when you feel fine.
Concerned about Pegloticase (Recombinant Uricase) Therapy Monitoring? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Your body may develop neutralizing antibodies against pegloticase because it recognizes the medication as a foreign substance. This immune response is more common in people who have had previous exposure to similar medications or who have very active immune systems. The antibodies bind to pegloticase and prevent it from breaking down uric acid effectively.
Risk factors for antibody development include missed infusions, longer gaps between doses, and certain genetic factors that affect immune response. When antibodies form, the medication becomes less effective and your uric acid levels can climb back to dangerous levels. Regular monitoring helps catch this problem early so your doctor can switch you to a different treatment approach.
How it's diagnosed
Pegloticase therapy monitoring is done through regular serum uric acid blood tests. Your doctor will check your uric acid levels before each infusion to confirm the medication is working. Effective treatment keeps uric acid below 6 mg/dL. If your levels rise above this target on two consecutive tests, it usually means neutralizing antibodies have developed.
Rite Aid offers uric acid testing through our preventive health panel at over 2,000 Quest Diagnostics locations nationwide. Regular testing between doctor visits gives you and your healthcare team more data points to track your treatment response. Getting tested regularly helps ensure you catch any problems with your therapy before they lead to serious gout flares.
Treatment options
- Continue pegloticase infusions every two weeks as prescribed by your doctor
- Get uric acid blood tests before each infusion to monitor treatment response
- Stop pegloticase if uric acid levels rise above 6 mg/dL on two tests
- Switch to alternative gout medications if antibodies develop
- Follow a low purine diet to reduce uric acid from food sources
- Stay well hydrated by drinking 8 to 12 cups of water daily
- Avoid alcohol, especially beer and spirits, which raise uric acid levels
- Take medications to prevent gout flares during early treatment
- Report any infusion reactions to your doctor immediately
- Work with a rheumatologist who specializes in gout management
Concerned about Pegloticase (Recombinant Uricase) Therapy Monitoring? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Your doctor will typically check your uric acid before each infusion, which means every two weeks. This frequent testing helps catch any problems with treatment response as early as possible. Some doctors may also recommend testing between infusions to get even more detailed tracking of your uric acid levels.
Rising uric acid levels during pegloticase therapy usually mean your body has developed neutralizing antibodies against the medication. These antibodies prevent the drug from working properly. If your uric acid goes above 6 mg/dL on two consecutive tests, your doctor will likely stop pegloticase and switch you to a different treatment approach.
No, continuing pegloticase after antibodies develop is not recommended. The medication will not work effectively once antibodies form, and continuing treatment increases your risk of serious infusion reactions. Your doctor will help you transition to alternative gout medications that can still control your uric acid levels.
The target uric acid level during pegloticase treatment is below 6 mg/dL. Many people on effective therapy achieve levels well below this target, sometimes as low as 1 to 2 mg/dL. Your doctor will use this threshold to determine if the medication is working properly.
Yes, pegloticase can cause infusion reactions including redness, itching, chest discomfort, and difficulty breathing. Some people experience increased gout flares when starting treatment. Your doctor will prescribe medications to prevent these reactions and monitor you closely during each infusion.
The duration of pegloticase treatment varies by person. Some people stay on it for several months until their uric acid crystals dissolve and tophi shrink. Others develop antibodies within weeks and need to switch treatments. Regular uric acid monitoring helps determine how long you can safely continue therapy.
Yes, following a low purine diet supports your pegloticase therapy by reducing the amount of uric acid your body makes from food. Avoid organ meats, certain seafood, and excessive alcohol. Drinking plenty of water also helps your kidneys flush out uric acid. Diet alone cannot replace medication, but it helps support your treatment.
Missing infusions increases your risk of developing neutralizing antibodies and losing treatment response. Try to keep all scheduled appointments. If you must miss an infusion, contact your doctor right away to reschedule. Gaps in treatment can compromise the effectiveness of your therapy.
Pegloticase can be used in people with kidney disease and is often prescribed when kidney problems prevent use of other gout medications. The medication works by breaking down uric acid directly rather than relying on kidney function to remove it. Your doctor will monitor both your kidney function and uric acid levels during treatment.
Your doctor may prescribe additional medications during pegloticase therapy to prevent gout flares and infusion reactions. However, you should not take certain medications like allopurinol at the same time as pegloticase. Always tell your doctor about all medications you are taking to avoid dangerous interactions.